Citation tools
"Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World." Anticancer Research
40.12
(2020):
7037-7043.
Web. 10 May. 2026.

